Cancers, Vol. 15, Pages 456: Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer

In conclusion, raloxifene or SC144 can enhance the anti-tumorigenic effects of paclitaxel, suggesting that paclitaxel doses might also be reduced in combined chemotherapy to lessen paclitaxel side effects.

Source: Cancers - January 11, 2023 Category: Cancer & Oncology Authors: Nina A. Hering Emily G ünzler Marco Arndt Miriam Zibell Johannes C. Lauscher Martin E. Kreis Katharina Beyer Hendrik Seeliger Ioannis Pozios Tags: Article Source Type: research